The results of a first prostate-specific antigen (PSA) test for males between the ages of 44 and 50 can predict the risk of dying of prostate cancer within the next 25 to 30 years, according to a new study.
Researchers analyzed blood samples collected from 12,090 Swedish men between 1974 and...
A new study suggests a way to help men with early, low-risk prostate cancer avoid being overtreated for a disease that in most cases will never threaten their lives. It found that a drug can slow the growth of these tumors in men who opt to be monitored instead of having treatment right away...
WEDNESDAY, Jan. 5 (HealthDay News) -- Prostate cancer patients who routinely engage in modest amounts of vigorous physical exercise appear to lower their risk of dying from their disease, new research suggests.
Three hours a week or more of vigorous biking, tennis, jogging or swimming seems to...
Robot-assisted prostate surgery effective
DETROIT, -- Nearly 87 percent of men who underwent robot-assisted prostate surgery had no recurrence of disease five years later, U.S. researchers found.
Study leader Dr. Mani Menon of Henry Ford Hospital in Detroit, a pioneer in minimally...
AALARD
Thread
pioneer
programming
prostate
robot-assisted
surgery
Stemming advanced prostate cancer growth
CHAPEL HILL, N.C., (UPI) -- U.S. researchers say their findings may open the door for new treatments for advanced prostate cancer.
Researchers at the University of North Carolina School of Medicine in Chapel Hill, N.C., say they are seeking to find out...